YMBA YM Bio. Com Shs

RNS Number:5654D
YM BioSciences Inc.
25 May 2006


YM BioSciences Inc. (the "Company")

The Company announces that 5,675,287 common shares have been issued as partial
vendor consideration in conjunction with the acquistion of Eximias
Pharmaceutical Corporation.  Application has been made for these shares to be
admitted to AIM.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEIIFIDEEIEFIR

YM Bio. Com Shs (LSE:YMBA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

YM Bio. Com Shs (LSE:YMBA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024